Found 10 matching trials
Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer
PHASE1Study to determine the best dose of stereotactic body radiation therapy (SB...
Location
University of Chicago Medical Center
Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer
PHASE2The purpose of this study is to see if the combination of nivolumab + cabir...
Location
UCSD Moores Cancer Center
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
PHASE1Phase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab...
Location
Scottsdale Healthcare Hospitals DBA Honor Health
An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
PHASE1The purpose of this study is to evaluate the treatment of solid tumors with...
Location
Local Institution - 0001
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
PHASE1This is a phase 1/2 single arm, open-label, safety, tolerability, and PK st...
Location
Cedars-Sinai Medical Center
Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer
PHASE2The purposed of this research is to study the safety and clinical activity ...
Location
Multiple Locations
A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread
PHASE1The purpose of this study is to determine whether an investigational immuno...
Location
Local Institution
A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
PHASE2The purpose of this study is to determine whether an investigational immuno...
Location
Mayo Clinic in Rochester, Minnesota
Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
PHASE2A multicenter trial evaluating the combination of nivolumab and the antagon...
Location
University of Michigan Comprehensive Cancer Center
Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects
PHASE1This is a Phase 1, randomized, double-blind, placebo-controlled study desig...
Location
BIK-Betegápoló Irgalmas rend-Budai Irgalmasrendi Kórház/Polyclinic of the Hospitaller Brothers of St. John of God in Budapest